At NorthEdge, we believe the UK regions are rich in opportunity for investment, where ambitious businesses can thrive.

One of our most recent deals is a multi-million-pound investment into contract research organisation (CRO) and trusted provider of immunology research services, Antibody Analytics – a business based just outside of Glasgow.

Headquartered in Motherwell, Antibody Analytics supports biopharmaceutical companies across the world by providing data to bring forward healthcare solutions and improve global health outcomes.

Shared far and wide by publications, the story was featured in The Herald and The Times Scotland, as well as prominent pharmaceutical titles, business press and the private equity media.

With this investment, Antibody Analytics will be able to expand its workforce and develop a new world-class facility. As well as further positioning Antibody Analytics as a world leader in pre-clinical immunology research services, our investment will have a wider positive impact too. We’re confident the deal will create an array of job opportunities across Scotland’s Life Sciences sector and will help facilitate growth within the region.

The healthcare sector is one of NorthEdge’s core investment focus areas and we are committed to investing in people, technology and infrastructure to support businesses that improve global health outcomes. Antibody Analytics represents our latest investment in this space and is another example of NorthEdge investing in a well-respected and cutting-edge global business based in the UK regions.

Read more about our investment, via The Herald, here.

To read more via The Times, view the article online, here.